Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: Interactions of double stranded DNA and doxorubicin modified with a carrier

Analytical Chemistry

Volumn 81, Issue 17, 2009, Pages 7474-7483

  Nowicka, Anna M ^a   Kowalczyk, Agata ^a   Donten, Mikolaj ^a   Krysinski, Pawel ^a   Stojek, Zbigniew ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRIAMYCIN; ANTICANCER DRUG; BINDING CONSTANT; CALF THYMUS; CANCER TREATMENT; COVALENTLY BOUND; DOUBLE STRANDED DNA; DOUBLE-STRANDED DNA (DS-DNA); DOXORUBICIN; DRUG CARRIER; ELECTROCHEMICAL TECHNIQUES; FERROFLUID; MAGNETIC DRUG TARGETING; MAGNETIC NANOPARTICLES; NANOFERRITES; SCANNING ELECTRON MICROSCOPY IMAGE; SIDE EFFECT; TARGETED DRUG DELIVERY;

ATOMIC FORCE MICROSCOPY; BINDING ENERGY; BINDING SITES; CHEMOTHERAPY; DNA; DRUG DELIVERY; GENES; MAGNETISM; MOLECULES; NANOPARTICLES; NUCLEIC ACIDS; SCANNING ELECTRON MICROSCOPY; TETHERLINES;

DRUG INTERACTIONS;

DOUBLE STRANDED DNA; DOXORUBICIN; FERROFLUID; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; BINDING SITE; CALF (BOVINE); DRUG DELIVERY SYSTEM; ELECTROCHEMICAL ANALYSIS; POTENTIOMETRY; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DNA; DOXORUBICIN; DRUG CARRIERS; MAGNETICS; NANOPARTICLES;

EID: 69749087173     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac9014534     Document Type: Article

References (64)

1. Häfeli, U. O.; Riffle, J. S.; Harris-Shekhawat, L.; Carmichael-Baranauskas, A.; Mark, F.; Dailey, J. P.; Bardenstein, D. Mol. Pharm. 2009, DOI:10.1021/mp900083m.
2. Shinkai, M. J. Biosci. Bioeng. 2002, 94, 606-613.
3. Alexiou, C.; Schmid, R. J.; Jurgons, R.; Kremer, M.;Wanner, G.; Bergemann, C.; Huenges, E.; Nawroth, T.; Arnold, W.; Parak, F. G. Eur. Biophys. J. 2006, 35, 446-450.
4. Rahn, H.; Gomez-Morilla, I.; Jurgons, R.; Alexiou, C.; Eberbeck, D.; Odenbach, S. J. Magn. Magn. Mater. 2009, 321, 1517-1520.
5. Tsutaoka, T. J. Appl. Phys. 2003, 93, 2789-2796.
6. Leslie-Pelecky, D. I.; Rieke, R. D. Chem. Mater. 1996, 8, 1770-1783.
7. Hartshorne, H.; Backhouse, C. J.; Lee, W. E. Sens. Actuators, B 2004, 99, 592-600.
8. Wan, W. K.; Yang, L.; Padavan, D. T. Nanomedicine 2007, 2, 483-509.
9. Bucak, S.; Jones, D. A.; Laibinis, P. E.; Hatton, T. A. Biotechnol. Prog. 2003, 19, 477-484.
10. Shen, L.; Laibinis, P. E.; Hatton, T. A. Langmuir 1999, 15, 447-453.
11. Giri, J.; Pradhan, P.; Somani, V.; Chelawat, H.; Chhatre, S.; Banerjee, R.; Bahadur, D. J. Magn. Magn. Mater. 2008, 320, 724-730.
12. Schneider, G.; Decher, G. Nano Lett. 2004, 4, 1833-1839.
13. Jun, Y.; Huh, Y.-M.; Choi, J.; Lee, J.-H.; Song, H.-T.; Kim, S.; Yoon, S.; Kim, K.-S.; Shin, J.-S.; Suh, J. S.; Cheon, J. J. Am. Chem. Soc. 2005, 127, 5732-5733.
14. Kim, J. S.; Rieter, W. J.; Taylor, K. M. L.; An, H.; Lin, W. L.; Lin, W. B. J. Am. Chem. Soc. 2007, 129, 8962-8963.
15. Grüttner, C.; Müller, K.; Teller, J.; Westphal, F.; Foreman, A.; Ivkov, R. J. Magn. Magn. Mater. 2007, 311, 181-186.
16. Neuberger, T.; Schöpf, B.; Hofmann, H.; Hofmann, M.; von Rechenberg, B. J. Magn. Magn. Mater. 2005, 293, 483-496.
17. Zhou, X.; Xing, D.; Zhu, D.; Jia, L. Electrochem. Commun. 2008, 10, 564-567.
18. Capanico, G.; Zunino, F. In Molecular Basis of Specificity in Nucleic Acid- Drug Interactions; Pullman, B., Jortner, J. , Eds.; Kluwer Academic Publishers: Dordrecht, The Netherlands, 1990; pp 167-176.
19. Duguet, M.; Lavenot, C.; Harper, F.; Mirambeau, G.; de Recondo, A.-M. Nuleic Acids Res. 1983, 11, 1059-1075.
20. D'Arpa, P.; Liu, L. F. Biochim. Biophys. Acta 1989, 989, 163-177.
21. Singha, B. K.; Mimnaugh, E. G. Free Radical Biol. Med. 1990, 8, 567-581.
22. Chaires, J. B.; Herrera, J. E.; Waring, M. Biochemistry 1990, 29, 6145-6153.
23. Kellogg, G. E.; Scarsdale, J. N.; Fornari, F. A. Nucleic Acid Res. 1998, 26, 4721-4732.
24. Kuwabara, T.; Noda, T.; Ohtake, H.; Ohtake, T.; Toyama, S.; Ikariyama, Y. Anal. Biochem. 2003, 314, 30-37.
25. Machala, L.; Zboril, R.; Gedanken, A. J. Phys. Chem. B 2007, 111, 4003-4018.
26. Reddy, K. R.; Lee, K.-P.; Iyengar, A.-G. J. Appl. Polym. Sci. 2007, 104, 4127-4134.
27. Majewski, P.; Krysinski, P. Chem. - Eur. J. 2008, 14, 7961-7968.
28. Kelepouris, L.; Krysiñski, P.; Blanchard, G. J. J. Phys. Chem. B 2003, 107, 4100-4106.
29. Krysinski, P.; Blanchard, G. Langmuir 2003, 19, 3875-3882.
30. Krysiñski, P.; Show, Y.; Stotter, J.; Blanchard, G. J. J. Am. Chem. Soc. 2003, 125, 12726-12728.
31. Krysinski, P.; Blanchard, G. Bioelectrochemistry 2005, 66, 71-77.
32. Brzozowska, M.; Krysinski, P. DOI: 10.1016/j.electacta.2008.11.018.
33. Lübbe, A. S.; Bergemann, C.; Riess, H.; Schriever, F.; Reichardt, P.; Possinger, K.; Matthias, M.; Dorken, B.; Herrmann, F.; Gurtler, R.; Hohenberger, P.; Haas, N.; Sohr, R.; Sander, B.; Lemke, A. J.; Ohlendorf, D.; Huhnt, W.; Huhn, D. Cancer Res. 1996, 56, 4686-4693.
34. Lübbe, A. S.; Bergemann, C.; Huhnt, W.; Fricke, T.; Riess, H.; Brock, J. W.; Huhn, D. Cancer Res. 1996, 56, 4694-4701.
35. Alexiou, C.; Jurgons, R.; Schmid, R. J.; Bergemann, C.; Henke, J.; Erhardt, W.; Huengens, E.; Parak, F. J. Drug Targeting 2003, 11, 139-149.
36. Chertok, B.; Moffat, B. A.; David, A. E.; Yu, F.; Bergemann, C.; Ross, B. D.; Yang, V. C. Biomaterials 2008, 29, 487-496.
37. Alexiou, C.; Schmid, R. J.; Jurgons, R.; Kremer, M.; Wanner, G.; Bergemann, C.; Huenges, E.; Nawroth, T.; Arnold, W.; Parak, F. G. Eur. Biophys. J. 2006, 35, 446-450.
38. Scatchard, G. Ann. N.Y. Acad. Sci. 1949, 51, 660-672.
39. McGhee, J. D.; von Hippel, P. H. J. Mol. Biol. 1974, 86, 469-489.
40. Carter, T. M.; Rodrigues, M. A.; Bard, A. J. J. Am. Chem. Soc. 1989, 111, 8901-8911.
41. McFadyen, W. D.; Sotirellis, N.; Denny, W. A.; Wakelin, P. G. Biochem. Biophys. Acta 1990, 1448, 50-58.
42. Brett, C. M. A.; Oliveira-Brett, A. M.; Serrano, S. H. P. J. Electroanal. Chem. 1994, 366, 225-231.
43. Ferapontova, E. Electrochim. Acta 2004, 49, 1751-1759.
44. Nowicka, A. M.; Zabost, E.; Donten, M.; Mazerska, Z.; Stojek, Z. Anal. Bioanal. Chem. 2007, 389, 1931-1940.
45. Kowalczyk, A.; Nowicka, A. M.; Karbarz, M.; Stojek, Z. Anal. Bioanal. Chem. 2008, 392, 463-469.
46. Lowen, J. W. Anthracycline and Anthracenechone Based Anticancer Agents; Elsevier: Amsterdam, The Netherlands, 1988.
47. Oliveira-Brett, A. M.; Piedade, J. A. P.; Silva, L. A.; Diculescu, V. C. Anal. Biochem. 2004, 332, 321-329.
48. Fojta, M. Eectroanalysis 2002, 21, 1449-1463.
49. Brabec, V.; Koudelka, J. Bioelectrochem. Bioenerg. 1980, 7, 69-82.
50. Wu, L.; Zhou, J.; Luo, J.; Lin, Z. Electrochim. Acta 2000, 45, 2923-2927.
51. Fojta, M.; Havran, L.; Fulneèková, J.; Kubièá rová, T. Electroanalysis 2000, 12, 926-934.
52. Nakatani, K.; Matsuno, T.; Adachi, K.; Hagihara, S.; Saito, I. J. Am. Chem. Soc. 2001, 123, 5695-5702.
53. Reynisson, J.; Schuster, G. B.; Howerton, S. B.; Williams, L. D.; Barnett, R. N.; Cleveland, C. L.; Landman, U.; Harrit, N.; Chaires, J. B. J. Am. Chem. Soc. 2003, 125, 2072-2083.
54. Silverman, R. B. In The Organic Chemistry of Drug Design and Drug Action, 2nd ed.; Elsevier, Academic Press: Amsterdam, The Netherlands, 2004; pp 342-352.
55. Millan, K. M.; Sarraullo, A.; Mikkelsen, S. R. Anal. Chem. 1994, 66, 2943-2948.
56. Xu, X.; Bard, A. J. J. Am. Chem. Soc. 1995, 117, 2627-2631.
57. Yang, M.; Yau, H. C. M.; Chan, H. L. Langmuir 1998, 14, 6121-6129.
58. Jacintho, G. V. M.; Corio, P.; Rubim, J. C. J. Electroanal. Chem. 2007, 603, 27-34.
59. Song, Y. M.; Kang, J. W.; Zhou, J.; Wang, Z. H.; Lu, X. Q.; Wang, L. F.; Gao, J. Z. Spectrochim. Acta, Part A 2000, 56, 2491-2497.
60. Ling, X.; Zhong, W.; Huang, Q.; Ni, K. J. Photochem. Photobiol., B 2008, 93, 172-176.
61. Borisova, O. F.; Shchyolkina, A. K.; Karapetyan, A. T.; Surovaya, A. N. Mol. Biol. 1998, 32, 718-724.
62. Schneider, Y. J.; Baurain, R.; Zenebergh, A.; Trouet, A. Cancer Chemother. Pharmacol. 1979, 2, 7-10.
63. Yang, M.; Chan, H. L.; Lam, W.; Fong, W. F. Biochim. Biophys. Acta 1998, 1380, 329-335.
64. Liang, Y.; Wang, C. X.; Zou, G. L.; Wang, Z. Y.; Liu, Y. W.; Qu, S. S. Thermochim. Acta 2000, 351, 21-27.